Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2015-03-06 17:09:56
Reporting Period:
Filing Date:
Accepted Time:
2015-03-06 17:09:56
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
701221 Cigna Corp CI Hospital & Medical Service Plans (6324) 061059331
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1500886 A Thomas Mccarthy 900 Cottage Grove Road
Bloomfield CT 06002
Evp, Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $.25 Par Value Acquisiton 2015-03-04 5,475 $40.56 66,687 No 4 M Direct
Common Stock, $.25 Par Value Disposition 2015-03-04 4,488 $120.74 62,199 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock, $.25 Par Value Employee Stock Option (Right to Buy) Disposition 2015-03-04 5,475 $0.00 5,475 $40.56
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2007-02-22 2016-02-22 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock, $.25 Par Value 1,169 Indirect By 401(k)
  1. Represents the weighted average price of the shares sold. The prices actually received ranged from $120.741 to $120.757 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.
  2. This option was granted on February 22, 2006. The option vested in three equal annual installments on the first, second and third anniversaries of the grant date.